Piperazine

Piperazine

SCHEMBL5946683

C1CNCCN1.NCCN.NCCN.NCCN

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ PDE4A P27815 1/20 0.55
▸ KDR P35968 1/20 0.55
▸ CXCR4 P61073 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL2882663 1.00 HIF1A (0.55) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL14739784 1.00 HIF1A (0.55) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL3905641 0.96 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Ethylenediamine SCHEMBL1030825 0.95 — —
Piperazine SCHEMBL3905644 0.92 HIF1A (0.46) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL9562685 0.84 NFKB1 (0.54) HIF1AMAPTPDE4AKDRCXCR4
Pyrrolidine SCHEMBL2814299 0.84 — —
Piperazine SCHEMBL4260232 0.81 HIF1A (0.43) HIF1AMAPTPDE4AKDRCXCR4
Piperidine SCHEMBL4128881 0.81 ALDH1A1 (0.64) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL22494138 0.81 DNM1 (0.57) HIF1AMAPTPDE4AKDRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107952467-A A kind of method for preparing catalyst of high selectivity piperazine triethylenediamine 西安近代化学研究所 2018-04-24 — — CN claimed
EP-0842935-B1 Process for the production of triethylenediamine AIR PROD & CHEM (US) 2003-05-07 — — EP claimed
CN-107952467-A A kind of method for preparing catalyst of high selectivity piperazine triethylenediamine 西安近代化学研究所 2018-04-24 — — CN disclosed
CN-107952467-A A kind of method for preparing catalyst of high selectivity piperazine triethylenediamine 西安近代化学研究所 2018-04-24 — — CN disclosed
CN-107952467-A A kind of method for preparing catalyst of high selectivity piperazine triethylenediamine 西安近代化学研究所 2018-04-24 — — CN disclosed
US-8512813-B2 Coating composition, coating film made of same, and optical article MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-08-20 — — US disclosed
EP-1650275-B1 COATING COMPOSITION, COATING FILM MADE OF SAME, AND OPTICAL ARTICLE MITSUBISHI GAS CHEMICAL CO (JP) 2013-06-26 — — EP disclosed
US-20120219807-A1 COATING COMPOSITION, COATING FILM MADE OF SAME, AND OPTICAL ARTICLE OKADA HIROYUKI (JP) 2012-08-30 — — US disclosed
US-20060167217-A1 Coating composition, coating film made of same, and optical article MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-07-27 — — US disclosed
EP-1650275-A1 COATING COMPOSITION, COATING FILM MADE OF SAME, AND OPTICAL ARTICLE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-04-26 — — EP disclosed
EP-0149186-B1 PROCESS FOR PREVENTING AGGLOMERATION OF POWDERS TOSOH CORPORATION (JP) 1988-03-16 — — EP disclosed
US-4559384-A Process for preventing agglomeration of powders by using triethylenediamine polymers TOYO SODA MANUFACTURING CO., LTD. (JP) 1985-12-17 — — US disclosed
EP-0149186-A2 Process for preventing agglomeration of powders TOSOH CORPORATION (JP) 1985-07-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167217-A1 Coating composition, coating film made of same, and optical article TET1, FDFT1, TMT1A HIF1A 2862/4885MAPT 374/4885PDE4A 2750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback